| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NAGENiagen Bioscience Inc | 503.58M | 6.31 | 57.36 | 19.18% | 16.38% | 28.91% | 2.37% | 0.06 |
| BTXBlackRock Technology and Private Equity Term Trust | 808.8M | 6.93 | 40.76 | -81.13% | 87.75% | 1.87% | 34.27% | |
| HALOHalozyme Therapeutics, Inc. | 8.45B | 71.82 | 20.94 | 22.44% | 47.91% | 118.17% | 5.55% | 4.14 |
| RPRXRoyalty Pharma plc | 16.97B | 39.72 | 20.80 | -3.86% | 32.55% | 7.95% | 16.32% | 0.74 |
| REGNRegeneron Pharmaceuticals, Inc. | 76.63B | 741.92 | 19.35 | 8.27% | 32.13% | 14.79% | 4.78% | 0.09 |
| GMABGenmab A/S | 20.85B | 33.85 | 2.79 | 30.67% | 46.8% | 114.25% | 36.37% | 0.03 |
| DNAGinkgo Bioworks Holdings, Inc. | 464.86M | 9.58 | -0.91 | -9.71% | -188% | -60.66% | 0.65 | |
| PRMEPrime Medicine, Inc. | 720.24M | 3.99 | -2.42 | -33.02% | -121.95% | 0.27 |
| Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 2.72M | 5.47M | 11.15M | 14.72M | 17.91M | 19.8M | 21.17M | 24.81M | 24.31M |
| Revenue Growth % | - | - | 1.01% | 1.04% | 0.32% | 0.22% | 0.11% | 0.07% | 0.17% | -0.02% |
| Cost of Goods Sold | 823 | 1.98M | 6.76M | 13.04M | 15.3M | 6.51M | 10.63M | 13.85M | 15.62M | 12.81M |
| COGS % of Revenue | - | 0.73% | 1.24% | 1.17% | 1.04% | 0.36% | 0.54% | 0.65% | 0.63% | 0.53% |
| Gross Profit | -823 | 743.76K | -1.29M | -1.89M | -576.29K | 11.4M | 9.17M | 7.32M | 9.19M | 11.5M |
| Gross Margin % | - | 0.27% | -0.24% | -0.17% | -0.04% | 0.64% | 0.46% | 0.35% | 0.37% | 0.47% |
| Gross Profit Growth % | 0.21% | 904.72% | -2.74% | -0.46% | 0.69% | 20.79% | -0.2% | -0.2% | 0.26% | 0.25% |
| Operating Expenses | 33.61K | 2.13M | 3.51M | 4.47M | 3.71M | 5.42M | 26.3M | 36.58M | 23.46M | 23.77M |
| OpEx % of Revenue | - | 0.78% | 0.64% | 0.4% | 0.25% | 0.3% | 1.33% | 1.73% | 0.95% | 0.98% |
| Selling, General & Admin | 33.61K | 1.45M | 3M | 3.97M | 3.24M | 13.27M | 18.05M | 18.19M | 19.14M | 19.03M |
| SG&A % of Revenue | - | 0.53% | 0.55% | 0.36% | 0.22% | 0.74% | 0.91% | 0.86% | 0.77% | 0.78% |
| Research & Development | 0 | 683.24K | 511.84K | 495.75K | 467.29K | 1.86M | 7.84M | 12.58M | 4.09M | 4.9M |
| R&D % of Revenue | - | 0.25% | 0.09% | 0.04% | 0.03% | 0.1% | 0.4% | 0.59% | 0.16% | 0.2% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -9.7M | 409.34K | 5.81M | 229.77K | -163.23K |
| Operating Income | -34.43K | -1.39M | -4.8M | -6.35M | -4.29M | -5.28M | -17.13M | -29.25M | -14.26M | -12.27M |
| Operating Margin % | - | -0.51% | -0.88% | -0.57% | -0.29% | -0.3% | -0.86% | -1.38% | -0.57% | -0.5% |
| Operating Income Growth % | 0.48% | -39.31% | -2.46% | -0.32% | 0.33% | -0.23% | -2.24% | -0.71% | 0.51% | 0.14% |
| EBITDA | -33.61K | -1.34M | -4.34M | -4.04M | -719.03K | -2.45M | -13.27M | -22.4M | -8.46M | -7.19M |
| EBITDA Margin % | - | -0.49% | -0.79% | -0.36% | -0.05% | -0.14% | -0.67% | -1.06% | -0.34% | -0.3% |
| EBITDA Growth % | 0.48% | -38.74% | -2.25% | 0.07% | 0.82% | -2.41% | -4.42% | -0.69% | 0.62% | 0.15% |
| D&A (Non-Cash Add-back) | 823 | 52.36K | 460.41K | 2.31M | 3.57M | 2.84M | 3.85M | 6.85M | 5.8M | 5.08M |
| EBIT | -34.23K | -5.64M | -5M | -6.91M | -4.81M | -6.65M | -16.12M | -28.4M | -29.03M | -33.96M |
| Net Interest Income | -259 | -16.77K | -10.85K | -827.63K | -451.46K | -337.37K | 194K | 92K | 4K | -9.91K |
| Interest Income | 0 | 0 | 73.37K | 30.7K | 284.81K | 265K | 279K | 122K | 23K | 0 |
| Interest Expense | 260 | 16.77K | 84.22K | 858.32K | 736.27K | 602.37K | 85K | 30K | 19K | 9.91K |
| Other Income/Expense | -63 | -4.27M | -285.76K | -1.41M | -1.25M | 705.68K | 920.4K | 818.65K | -14.79M | -21.7M |
| Pretax Income | -34.49K | -5.66M | -5.09M | -7.77M | -5.54M | -4.58M | -16.21M | -28.43M | -29.05M | -33.97M |
| Pretax Margin % | - | -2.08% | -0.93% | -0.7% | -0.38% | -0.26% | -0.82% | -1.34% | -1.17% | -1.4% |
| Income Tax | 0 | -85.22K | 110.27K | 4.88K | -362K | 1.34M | 880.52K | -1.22M | -2.62M | -4M |
| Effective Tax Rate % | 1% | 0.98% | 1.02% | 1% | 0.93% | 1.6% | 1.05% | 0.96% | 0.91% | 0.88% |
| Net Income | -34.49K | -5.57M | -5.2M | -7.77M | -5.18M | -7.34M | -17.09M | -27.21M | -26.43M | -29.97M |
| Net Margin % | - | -2.05% | -0.95% | -0.7% | -0.35% | -0.41% | -0.86% | -1.29% | -1.07% | -1.23% |
| Net Income Growth % | 0.45% | -160.48% | 0.07% | -0.5% | 0.33% | -0.42% | -1.33% | -0.59% | 0.03% | -0.13% |
| Net Income (Continuing) | -34.49K | -5.57M | -5.2M | -7.77M | -5.18M | -7.34M | -17.09M | -27.21M | -26.43M | -29.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.10 | -1.36 | -0.57 | -0.61 | -0.36 | -0.45 | -0.85 | -1.07 | -1.02 | -0.90 |
| EPS Growth % | 1.91% | -14.6% | 0.58% | -0.07% | 0.41% | -0.25% | -0.89% | -0.26% | 0.05% | 0.12% |
| EPS (Basic) | 0.10 | -1.36 | -0.57 | -0.61 | -0.36 | -0.45 | -0.85 | -1.07 | -1.02 | -0.90 |
| Diluted Shares Outstanding | 2M | 3.96M | 9.11M | 12.54M | 13.63M | 16.47M | 19.69M | 24.9M | 25.64M | 33.38M |
| Basic Shares Outstanding | 2M | 3.96M | 9.11M | 12.54M | 13.63M | 16.47M | 19.69M | 24.9M | 25.64M | 33.38M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.22M | 3.28M | 4.78M | 9.88M | 7.7M | 48.86M | 37.47M | 16.79M | 11.49M | 18.75M |
| Cash & Short-Term Investments | 555.02K | 2.58M | 1.81M | 5.47M | 2.61M | 41.76M | 29.96M | 8.28M | 3.46M | 10.66M |
| Cash Only | 340.88K | 2.58M | 1.81M | 5.47M | 2.61M | 41.76M | 29.96M | 8.28M | 3.46M | 10.66M |
| Short-Term Investments | 214.14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 450.91K | 469.49K | 2.22M | 1.95M | 3.66M | 3.63M | 3.41M | 3.88M | 4.07M | 4.81M |
| Days Sales Outstanding | - | 62.97 | 148.24 | 63.9 | 90.76 | 73.93 | 62.83 | 66.87 | 59.83 | 72.16 |
| Inventory | 2.79K | 58.5K | 412.69K | 2.12M | 818.64K | 1.2M | 1.61M | 2.06M | 2.14M | 2.1M |
| Days Inventory Outstanding | 1.24K | 10.8 | 22.28 | 59.38 | 19.53 | 67.53 | 55.46 | 54.3 | 49.99 | 59.7 |
| Other Current Assets | 209.05K | 61.15K | 0 | 0 | 89.09K | 491K | 0 | 536K | 414K | 0 |
| Total Non-Current Assets | 162.65K | 644.58K | 19.79M | 18.47M | 19.56M | 18.1M | 56.02M | 61.02M | 48.5M | 25.69M |
| Property, Plant & Equipment | 162.65K | 644.58K | 1.58M | 1.64M | 3.17M | 4.08M | 3.71M | 10.72M | 16.7M | 16.26M |
| Fixed Asset Turnover | - | 4.22x | 3.46x | 6.80x | 4.65x | 4.39x | 5.34x | 1.97x | 1.49x | 1.49x |
| Goodwill | 0 | 0 | 4.89M | 8.25M | 7.91M | 7.78M | 19.7M | 19.17M | 7.69M | 8.23M |
| Intangible Assets | 0 | 0 | 4.04M | 8.42M | 8.29M | 6.06M | 32.39M | 30.93M | 23.56M | 1.07M |
| Long-Term Investments | 0 | 0 | 90.4K | 90.4K | 118.9K | 111K | 142K | 115K | 62.6K | 91.22K |
| Other Non-Current Assets | 0 | 0 | 9.19M | 67.45K | 85.13K | 79K | 82K | 86K | 498.4K | 34.78K |
| Total Assets | 1.38M | 3.93M | 24.58M | 28.35M | 27.26M | 66.96M | 93.49M | 77.81M | 59.99M | 44.44M |
| Asset Turnover | - | 0.69x | 0.22x | 0.39x | 0.54x | 0.27x | 0.21x | 0.27x | 0.41x | 0.55x |
| Asset Growth % | 28.93% | 1.85% | 5.25% | 0.15% | -0.04% | 1.46% | 0.4% | -0.17% | -0.23% | -0.26% |
| Total Current Liabilities | 385.52K | 836.91K | 4.28M | 7.2M | 7.93M | 6.07M | 9.26M | 5.92M | 8.12M | 9.01M |
| Accounts Payable | 100.81K | 664.45K | 2.03M | 1.59M | 1.35M | 1.34M | 3.92M | 2.48M | 4.07M | 5.28M |
| Days Payables Outstanding | 44.71K | 122.63 | 109.63 | 44.63 | 32.3 | 75.43 | 134.5 | 65.47 | 95.16 | 150.54 |
| Short-Term Debt | 0 | 0 | 187.81K | 2.79M | 2.12M | 801.5K | 1.31M | 822.83K | 1.14M | 1.34M |
| Deferred Revenue (Current) | 279.33K | 172.47K | 317.54K | 724.69K | 1000K | 1000K | 1000K | 720.34K | 0 | 1000K |
| Other Current Liabilities | 284.71K | 0 | 2.05M | 2.78M | 2.23M | 22.5K | 1.13M | -127.17K | 1.35M | -1.03M |
| Current Ratio | 3.16x | 3.92x | 1.12x | 1.37x | 0.97x | 8.05x | 4.05x | 2.84x | 1.41x | 2.08x |
| Quick Ratio | 3.15x | 3.85x | 1.02x | 1.08x | 0.87x | 7.85x | 3.87x | 2.49x | 1.15x | 1.85x |
| Cash Conversion Cycle | - | -48.87 | 60.9 | 78.65 | 77.98 | 66.02 | -16.21 | 55.69 | 14.65 | -18.68 |
| Total Non-Current Liabilities | 86.63K | 0 | 7.59M | 3.07M | 4.25M | 3.96M | 9.07M | 14.09M | 17.94M | 11.8M |
| Long-Term Debt | 0 | 0 | 3.59M | 28.72K | 503K | 1.53M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 38.98K | 71.32K | 1.13M | 940K | 468K | 6.15M | 12.12M | 11.55M |
| Deferred Tax Liabilities | 86.63K | 0 | 882.34K | 1.94M | 1.6M | 1.49M | 8.11M | 7.66M | 5.83M | 250K |
| Other Non-Current Liabilities | 0 | 0 | 3.96M | 2.97M | 0 | 1.49M | 497K | 278K | 5.83M | 0 |
| Total Liabilities | 472.15K | 836.91K | 11.87M | 10.28M | 12.18M | 10.04M | 18.36M | 20.01M | 26.07M | 20.82M |
| Total Debt | 0 | 0 | 3.82M | 2.93M | 4.51M | 3.46M | 2.77M | 7.27M | 13.68M | 13.4M |
| Net Debt | -340.88K | -2.58M | 2.01M | -2.54M | 1.9M | -38.3M | -27.2M | -1.01M | 10.22M | 2.74M |
| Debt / Equity | - | - | 0.30x | 0.16x | 0.30x | 0.06x | 0.04x | 0.13x | 0.40x | 0.57x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -132.47x | -82.73x | -57.01x | -7.40x | -5.82x | -8.77x | -201.50x | -975.11x | -750.64x | -1237.63x |
| Total Equity | 908.26K | 3.09M | 12.7M | 18.07M | 15.09M | 56.92M | 75.28M | 57.8M | 33.92M | 23.63M |
| Equity Growth % | 5.36% | 2.4% | 3.11% | 0.42% | -0.17% | 2.77% | 0.32% | -0.23% | -0.41% | -0.3% |
| Book Value per Share | 0.45 | 0.78 | 1.39 | 1.44 | 1.11 | 3.46 | 3.82 | 2.32 | 1.32 | 0.71 |
| Total Shareholders' Equity | 908.26K | 3.09M | 12.7M | 18.07M | 15.09M | 56.92M | 75.28M | 57.8M | 33.92M | 23.63M |
| Common Stock | 232 | 7.46M | 20.46M | 32.7M | 34.09M | 80.1M | 114.56M | 117.47M | 119.77M | 136.37M |
| Retained Earnings | 907.93K | -4.57M | -9.74M | -17.48M | -22.48M | -29.82M | -46.53M | -73.09M | -100.27M | -128.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -686.61K | -737.22K | 277.09K | -228.06K | -300.22K | -687K | -2.48M | 2.63M | 2.02M | 3.22M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 284.09K | -721.65K | -3.42M | -3.21M | -1.39M | -600K | -9.92M | -19.83M | -4.25M | -6.41M |
| Operating CF Margin % | - | -0.27% | -0.62% | -0.29% | -0.09% | -0.03% | -0.5% | -0.94% | -0.17% | -0.26% |
| Operating CF Growth % | 8.87% | -3.54% | -3.73% | 0.06% | 0.57% | 0.57% | -15.54% | -1% | 0.79% | -0.51% |
| Net Income | 151.03K | -5.38M | -5.17M | -7.62M | -4.95M | -7.34M | -16.71M | -26.56M | -27.18M | -30.23M |
| Depreciation & Amortization | 41.88K | 50.61K | 458.08K | 2.26M | 3.41M | 3.71M | 3.77M | 6.68M | 5.74M | 5.12M |
| Stock-Based Compensation | 0 | 198.03K | 1.22M | 1.11M | 739.01K | 2.75M | 3.08M | 1.94M | 1.53M | 445K |
| Deferred Taxes | 0 | -82.38K | 63.39K | -578.97K | -455.16K | -83K | -336K | -926K | -1.77M | -3.94M |
| Other Non-Cash Items | 19.34K | 4.12M | 205.19K | 1.03M | 982.13K | 1.38M | -310K | 2.3M | 15.68M | 21.92M |
| Working Capital Changes | 71.83K | 380.69K | -193.38K | 580.64K | -1.12M | -1.02M | 582K | -3.28M | 1.76M | 276.99K |
| Change in Receivables | -74.9K | -46.8K | -284.95K | 102.11K | -933.28K | -439K | 163K | -561K | -241K | -391.8K |
| Change in Inventory | 0 | -58.5K | -27.94K | 289.52K | -23.39K | -316K | -501K | -185K | -102K | 99.03K |
| Change in Payables | 0 | 592.86K | 482.99K | -421.67K | 172K | -73K | 781K | -1.55M | 727.98K | 593.45K |
| Cash from Investing | -81.59K | -174.61K | -7.17M | -2.2M | -1.58M | -2.46M | -5.21M | -1.97M | -1.56M | -799K |
| Capital Expenditures | -17.48K | -530.75K | -345.49K | -645.06K | -575.64K | -1.43M | -1.26M | -1.5M | -1.4M | -799K |
| CapEx % of Revenue | - | 0.2% | 0.06% | 0.06% | 0.04% | 0.08% | 0.06% | 0.07% | 0.06% | 0.03% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -64.11K | 214.14K | 0 | 0 | 0 | 0 | -259K | 40K | -141K | 0 |
| Cash from Financing | -91.91K | 3.17M | 9.8M | 9.35M | 174.7K | 43.38M | 2.88M | -621K | 1.02M | 14.89M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | -65K | -90K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | -1.15M | -29.67K | -288.5K | 701 | 0 | -5K | 0 | 612.26K | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | 266.61K | -1.25M | -3.76M | -3.85M | -1.97M | -2.03M | -11.18M | -21.33M | -5.64M | -7.21M |
| FCF Margin % | - | -0.46% | -0.69% | -0.35% | -0.13% | -0.11% | -0.56% | -1.01% | -0.23% | -0.3% |
| FCF Growth % | 5.73% | -5.7% | -2% | -0.02% | 0.49% | -0.03% | -4.51% | -0.91% | 0.74% | -0.28% |
| FCF per Share | 0.13 | -0.32 | -0.41 | -0.31 | -0.14 | -0.12 | -0.57 | -0.86 | -0.22 | -0.22 |
| FCF Conversion (FCF/Net Income) | -8.24x | 0.13x | 0.66x | 0.41x | 0.27x | 0.08x | 0.58x | 0.73x | 0.16x | 0.21x |
| Interest Paid | 0 | 0 | 533 | 371.26K | 301K | 120K | 38K | 263K | 0 | 0 |
| Taxes Paid | 0 | 0 | 152.17K | 415.14K | 238K | 1.1M | 1.19M | 591K | 0 | 2K |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -9.86% | -278.48% | -65.81% | -50.52% | -31.25% | -20.39% | -25.85% | -40.9% | -57.63% | -104.17% |
| Return on Invested Capital (ROIC) | -12.04% | -192.58% | -47.29% | -31.52% | -19.78% | -22.26% | -38.51% | -41.84% | -21.2% | -26.1% |
| Gross Margin | - | 27.33% | -23.63% | -16.92% | -3.92% | 63.67% | 46.32% | 34.59% | 37.05% | 47.31% |
| Net Margin | - | -204.67% | -95.03% | -69.72% | -35.19% | -40.98% | -86.29% | -128.53% | -106.51% | -123.3% |
| Debt / Equity | - | - | 0.30x | 0.16x | 0.30x | 0.06x | 0.04x | 0.13x | 0.40x | 0.57x |
| Interest Coverage | -132.47x | -82.73x | -57.01x | -7.40x | -5.82x | -8.77x | -201.50x | -975.11x | -750.64x | -1237.63x |
| FCF Conversion | -8.24x | 0.13x | 0.66x | 0.41x | 0.27x | 0.08x | 0.58x | 0.73x | 0.16x | 0.21x |
| Revenue Growth | - | - | 100.96% | 103.86% | 32.03% | 21.69% | 10.56% | 6.92% | 17.19% | -2.03% |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Project Revenue | 17.36M | 18.68M | 22.23M | 22.18M |
| Project Revenue Growth | - | 7.61% | 19.05% | -0.27% |
| Product Sales | 1.65M | 1.75M | 2.04M | 2.11M |
| Product Sales Growth | - | 5.75% | 16.49% | 3.54% |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| UNITED STATES | 6.82M | 9.37M | 12.56M | 12.61M |
| UNITED STATES Growth | - | 37.40% | 34.07% | 0.46% |
| Europe | 9.43M | 9.45M | 10.87M | 10.18M |
| Europe Growth | - | 0.22% | 14.99% | -6.34% |
| AUSTRALIA | 1.54M | 630K | 482K | 896K |
| AUSTRALIA Growth | - | -59.09% | -23.49% | 85.89% |
| All Other Countries | 1.01M | 602K | 224K | 598K |
| All Other Countries Growth | - | -40.22% | -62.79% | 166.96% |
| CANADA | 572K | 618K | 389K | 234K |
| CANADA Growth | - | 8.04% | -37.06% | -39.85% |
MindWalk Holdings Corp. (HYFT) reported $20.5M in revenue for fiscal year 2025.
MindWalk Holdings Corp. (HYFT) saw revenue decline by 2.0% over the past year.
MindWalk Holdings Corp. (HYFT) reported a net loss of $30.6M for fiscal year 2025.
MindWalk Holdings Corp. (HYFT) has a return on equity (ROE) of -104.2%. Negative ROE indicates the company is unprofitable.
MindWalk Holdings Corp. (HYFT) had negative free cash flow of $10.3M in fiscal year 2025, likely due to heavy capital investments.